Publications
2023
- Accidents vasculaires cérébraux suivant l’administration d’un vaccin contre la COVID-19
- Zona survenu à la suite de la vaccination contre la COVID-19 au Québec
- Paralysie de Bell survenue à la suite de la vaccination contre la COVID-19 au Québec
- Manifestations cliniques indésirables à la suite de la vaccination de base contre la COVID-19 déclarées au système de surveillance passive du Québec
- Surveillance active de la sécurité des trois premières doses de vaccin contre la COVID-19 au Québec
- Administration of COVID-19 booster doses: Recommendations for winter and spring 2023
- Administration de doses de rappel du vaccin contre la COVID-19 : recommandations pour l’hiver et le printemps 2023
2022
- Administration d’une dose de vaccin bivalent aux personnes vaccinées avec le vaccin monovalent contre la COVID-19 depuis le 15 août 2022
- Vaccination contre l’influenza et la COVID-19 à l’automne 2022
- Stratégie vaccinale contre la COVID-19 à préconiser au Québec en 2022 et pertinence d’une 2e dose de rappel pour certains groupes vulnérables
- Administration des doses subséquentes d’un vaccin contre la COVID-19 chez les personnes ayant développé une péricardite ou une myocardite
- Enquête épidémiologique sur les travailleurs de la santé atteints par la COVID-19
- Vaccination contre l’hépatite virale A suite à une éclosion à Nunavik
Publications
2017
- Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.
- Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
- RE: "DETECTABLE RISKS IN STUDIES OF THE FETAL BENEFITS OF MATERNAL INFLUENZA VACCINATION"
- Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017.
- Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement.
- Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada
- Prevalence of risk factors for acquiring measles during the 2011 outbreak in Quebec and impact of the province-wide school-based vaccination campaign on population immunity.
- Selection Bias in the Assessment of Frailty and Its Role in Influenza Vaccine Effectiveness Evaluation Among Elderly Adults
2016
- Repeat Influenza Vaccination and High-Dose Efficacy.
- Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings.
- A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.
- Rapid surveillance for health events following a mass meningococcal B vaccine program in a university setting: A Canadian Immunization Research Network study.
- The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza.
- Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.